Attention Shareholders: Manzo Pharmaceuticals Due Diligence Report - BrokerBank Securities

NEW YORK, Oct. 19, 2015 /PRNewswire/ -- Manzo Pharmaceuticals, Inc. (OTCBB: MNZO) closed the trading at $.0007 up 133% on October 15^th and promptly returned 28% on the following day. MNZO shares traded between $.001 and $.0017 for most of this year before hitting a low of $.0001 earlier this month.

Interested parties will want to read our due diligence on Manzo Pharmaceuticals. Get our due diligence report at the link below. There is no cost to read the full report.

http://bit.ly/-MNZO_Due_Diligence

Copy and paste to browser may be required.

About Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notably is a patented solution for lactose intolerance, a natural sleep aid, and a natural remedy for colic in babies.

FORWARD-LOOKING DISCLAIMER   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. This release and report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this release have not been compensated in any form by any source. A full disclaimer can be found by viewing due diligence. We are only human and may make mistakes. If you notice any errors or omissions, please notify us below.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE BrokerBank Securities, Inc.

Related Links

http://www.brokerbanksecurities.com